Diet patterns · October 31, 2026
A Mediterranean diet score written in the blood tracked with lower mortality — but it is not a shortcut test
Researchers followed a blood-based signature of a Mediterranean-style diet across four long-running cohorts. People with higher scores had lower mortality rates, yet the study is a reminder that a promising biomarker can describe an association without becoming a personal prediction or a prescription.

Food questionnaires are useful, but they ask people to remember a lot: what was on a plate, how often, how much and how it was prepared. A new analysis in The American Journal of Clinical Nutrition asked a different question. Could a pattern of small molecules in blood offer another way to capture how closely someone's eating and metabolism resemble a Mediterranean-style diet?
The researchers used a previously developed signature made from 67 blood metabolites, selected from 302 measured compounds. It is not a test for whether someone had olive oil at lunch. Rather, it is a combined pattern that tended to be higher in people whose diets more closely matched the familiar Mediterranean mix of olive oil, vegetables, fruit, legumes, nuts and fish. The key distinction matters: metabolites reflect both food exposure and the way an individual body processes it.
Their first analysis came from PREDIMED, a Spanish nutrition trial that enrolled adults at high cardiovascular risk but without cardiovascular disease at the start. Of 7,447 trial volunteers, 1,880 had the baseline blood measurements needed for this analysis and 1,648 had a second measure after one year. The median follow-up was about 13 years. Compared with people in the lowest third of the blood-signature score, those in the highest third had a 23% lower relative hazard of death from any cause after the researchers' adjustments.
That pattern did not rest on one cohort. The team also tested it in 12,704 participants from the Nurses' Health Studies and the Health Professionals Follow-up Study in the United States, followed for roughly 25 years on average. Here too, the highest fifth of the signature score was associated with a 23% lower relative hazard of death than the lowest fifth. Across both settings, a one-standard-deviation higher score was linked with a lower rate of all-cause mortality; in the Spanish group, the one-year score was also associated with lower cardiovascular mortality.
The interesting part is not that blood can replace eating well. It cannot. A single score cannot tell a person which food to add, whether they need treatment, or what will happen to them. The authors did not find a statistically significant association with cancer mortality after full adjustment, and changes in the score over the first year were not significantly associated with later mortality. The study is also observational for the score-outcome question, even though PREDIMED itself was a trial, so it cannot prove that raising this number causes a longer life.
Still, the work offers a useful research direction. Self-reported diet and biology do not always agree, and a blood signature may capture a longer-running pattern that a questionnaire misses. For everyday eating, the study supports the less dramatic message rather than a new diet hack: build meals around plants, legumes, nuts, fish where it suits you, and unsaturated fats such as olive oil — then adapt the details to your culture, budget, health needs and advice from your clinician.
A metabolomic signature of the Mediterranean diet predicts mortality in 4 independent cohorts (American Journal of Clinical Nutrition, 2026)
67
Blood metabolites in the dietary signature, selected from 302 measured compounds
1,880
PREDIMED participants with baseline metabolomic data; 1,648 also had a one-year measurement
23% lower
Relative hazard of all-cause death for the highest versus lowest third of the baseline score in PREDIMED
12,704
Participants in the three U.S. replication cohorts, followed for about 25 years on average
4,111
Deaths recorded in the U.S. replication cohorts, including 845 cardiovascular and 1,231 cancer deaths
The analysis used a 67-metabolite plasma signature as an objective marker related to Mediterranean-diet adherence. PREDIMED was a Spanish trial of adults at high cardiovascular risk without cardiovascular disease at baseline; its parent trial enrolled 7,447 volunteers, while 1,880 had baseline metabolomics data for this analysis. Participants were assigned to a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with mixed nuts, or a low-fat control diet. Mortality associations for the metabolite score are observational and adjusted for measured factors, not proof that changing the score causes longer life. In PREDIMED, the average follow-up was about 13.2 years. The U.S. replication combined the Nurses' Health Studies I and II with the Health Professionals Follow-up Study. Figures from the paper's abstract and study report.
- The word metabolome describes the changing collection of small molecules in the body — a snapshot shaped by food, medicines, microbes and metabolism, not a food diary in disguise.
- PREDIMED's three groups were not simply labelled 'good' and 'bad' diets: two Mediterranean-diet groups received different additions, extra-virgin olive oil or mixed nuts, and the comparison group received low-fat dietary advice.
- The 67-metabolite pattern was measured with liquid chromatography-tandem mass spectrometry, a laboratory method that separates and identifies molecules by their chemical behaviour and mass.
- In the U.S. replication cohorts, most participants were women (83.2%) and their average age was 54.7 years, so results should not be treated as equally precise for every population.
- A relative hazard describes a difference in rates between groups over time. It does not reveal an individual's absolute chance of dying or the years of life any one dietary change would add.
- A metabolomic signature of the Mediterranean diet predicts mortality in 4 independent cohortsThe American Journal of Clinical Nutrition · Original peer-reviewed study, published in October 2026; study design, cohort sizes, follow-up and mortality associations
- Scientists found a link between Mediterranean diet blood markers and longer survivalNews-Medical · Plain-language report of the study, published 20 October 2026; used to cross-check the reported figures and limitations
- Air Olive 1Wikimedia Commons · Cover image by Volodymyr Vlasenko, CC BY-SA 3.0
General information, not medical advice. This study reports associations in groups of participants; it does not show that a blood test, supplement or one food will prevent disease or extend life for an individual. If you have heart disease, diabetes, kidney disease, an eating disorder, or take medicines affected by diet, discuss changes with your doctor or a registered dietitian.
Analysis by NutroPractic from the sources listed. Written for general readers; it does not replace advice from your own doctor.
From our articles
Read, then eat a little better
Plain-language guides on nutrition and wellness, backed by research.

Diabetes
Potatoes and blood sugar: boiled, cooled, mashed or fried, and what the cohorts and trials found
Fries were linked to 20% higher diabetes risk per three servings a week in 205,000 US adults; boiled, baked and mashed potatoes to almost none. GI by cooking method, resistant starch in grams after chilling, the glycaemic load of a potato against a cup of rice, and how to fit aloo into an Indian plate.
30 Oct 2026

Children's nutrition
Picky eaters aged 2 to 8: what feeding studies show works at the table
Fussy eating peaks between two and six and is usually a normal stage, not a parenting failure. Feeding trials show what moves it: small repeated tastes, eating together, no pressure and the right kind of reward. Here is how to use them, and the signs that mean it's more than picky eating.
30 Oct 2026

Women's health
PCOS and food: what the diet trials show for cycles, insulin and weight
PCOS affects about one woman in ten, and most are told to "lose weight" with little else. Here is what drives it, why insulin matters even in slim women, how much weight loss brings cycles back, what the low-GI and Mediterranean trials found, what inositol and metformin do, and which tests to ask for.
30 Oct 2026
Newsfeed for your website
Want this feed on your website?
Add it to any site with one copy-and-paste snippet. No sign-up, and it updates itself every hour.
Start with a virtual consultation
Tell Dr. Triveni what you want to change. You will leave with a clear next step, whether you are in Toronto, London, New York or Chennai.